Murphy & Mullick Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Murphy & Mullick Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.7K	Hold	1,500	–	–	0.01%	402
2026 Q1	$20.8K	Hold	1,500	–	–	0.02%	393
2025 Q4	$21.1K	Hold	1,500	–	–	0.02%	395
2025 Q3	$21K	Hold	1,500	–	–	0.02%	383
2025 Q2	$21.3K	Hold	1,500	–	–	0.02%	373
2025 Q1	$19.8K	Hold	1,500	–	–	0.02%	368
2024 Q4	$23.7K	Buy	+1,500	New	+$22.5K	0.02%	339

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Murphy & Mullick Capital Management's RDY Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 1,500 shares worth $21.7K. The position accounts for 0.01% of the portfolio, ranked #402.

Murphy & Mullick Capital Management first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $23.7K in Q4 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Murphy & Mullick Capital Management held 1,500 shares of Dr. Reddy's Laboratories worth $21.7K as of Q2 2026.
Murphy & Mullick Capital Management left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #402 holding.
Murphy & Mullick Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
Murphy & Mullick Capital Management's Dr. Reddy's Laboratories position peaked at $23.7K in Q4 2024.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.